BLRX
BioLineRX
BLRX
BLRX
31 hedge funds and large institutions have $1.34M invested in BioLineRX in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
44% less capital invested
Capital invested by funds: $2.42M → $1.34M (-$1.08M)
Holders
31
Holding in Top 10
–
Calls
$31K
Puts
$3K
Top Buyers
| 1 | +$69.2K | |
| 2 | +$23.7K | |
| 3 | +$18K | |
| 4 |
AI
Atria Investments
Charlotte,
North Carolina
|
+$15.6K |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$13.6K |
Top Sellers
| 1 | -$583K | |
| 2 | -$53.7K | |
| 3 | -$26.3K | |
| 4 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
-$18.3K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$11.3K |